FEIBA Side Effects

7022455-9 | Dialysis, Haemorrhage, Renal Failure, Sepsis, Thrombosis In Device
on Sep 20, 2010 Male patient from UNITED STATES , 53 years of age, was diagnosed with acquired haemophilia, factor viii deficiency and was treated with Feiba (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), haemorrhage, renal failure, sepsis (What is sepsis?), thrombosis in device. Feiba dosage: .

6970383-7 | Cerebrovascular Accident, Epilepsy, Pneumonia
Patient was taking Feiba (View Usage). Patient had the following side effects: cerebrovascular accident, epilepsy (What is epilepsy?), pneumonia (What is pneumonia?) on Jun 14, 2010 from BELGIUM Additional patient health information: Male patient , 70 years of age, was diagnosed with haemorrhage, haemophilia, factor viii inhibition and. Feiba dosage: . Patient was hospitalized.

6970370-9 | Oedema Peripheral, Weight Increased
Adverse event was reported on Jun 02, 2010 by a Female patient taking Feiba (View Usage) (Dosage: ) was diagnosed with acquired haemophilia, factor viii inhibition, diabetes mellitus, anaemia, hyponatraemia and. Location: FRANCE , 59 years of age, weighting 88.18 lb, After Feiba was administered, patient had the following side effects: oedema peripheral, weight increased. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), STEROGYL (View Sterogyl Review and Sterogyl Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

6970361-8 | Rectal Haemorrhage
on Dec 03, 2009 Male patient from FINLAND , 41 years of age, weighting 167.6 lb, was diagnosed with haemorrhage, pain (What is pain?) and was treated with Feiba (View Usage). Patient experienced the following unwanted or unexpected effects: rectal haemorrhage. Feiba dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OPIAT (View Opiat Review and Opiat Label ), FIBRIN SEALANT NOS (View Fibrin Sealant Nos Review and Fibrin Sealant Nos Label ). Patient was hospitalized.


6970356-4 | Arthralgia, Arthropathy, Haemorrhage
on Jun 26, 2009 Male patient from FINLAND , weighting 187.4 lb, was diagnosed with prophylaxis and was treated with Feiba (View Usage). Patient had the following side effects: arthralgia, arthropathy, haemorrhage. Feiba dosage: . Patient was hospitalized.

6970353-9 | Transfusion Reaction
Patient was taking Feiba (View Usage). After Feiba was administered, patient had the following side effects: transfusion reaction on Jun 19, 2009 from SPAIN Additional patient health information: Male patient , child 11 years of age, weighting 112.4 lb, was diagnosed with haemorrhage and. Feiba dosage: . During the same period patient was treated with FANHDI (View Fanhdi Review and Fanhdi Label ).

6970344-8 | Pneumonia
Adverse event was reported on Jan 15, 2010 by a Male patient taking Feiba (View Usage) (Dosage: ) was diagnosed with haemophilia, factor viii inhibition, pain (What is pain?), plasmin inhibitor decreased and. Location: UNITED KINGDOM , child 7 years of age, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). During the same period patient was treated with KOGENATE FS (View Kogenate Fs Review and Kogenate Fs Label ), FANDHI (View Fandhi Review and Fandhi Label ), ORAMORPH SR (View Oramorph Sr Review and Oramorph Sr Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ).

6968321-6 | Disseminated Intravascular Coagulation, Haemoglobin Decreased, Multi-organ Failure, Urticaria
on Aug 27, 2010 Male patient from JAPAN , 79 years of age, weighting 101.4 lb, was diagnosed with haemostasis, acquired haemophilia and was treated with Feiba (View Usage). Patient had the following side effects: disseminated intravascular coagulation, haemoglobin decreased, multi-organ failure, urticaria. Feiba dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), ENDOXAN (View Endoxan Review and Endoxan Label ).

6963251-8 | Cardiopulmonary Failure, Multi-organ Failure
on Aug 23, 2010 Male patient from UNITED STATES , 32 years of age, weighting 183.0 lb, was diagnosed with factor viii deficiency, factor viii inhibition, pain (What is pain?), candidiasis, fluid overload, allergy prophylaxis and was treated with Feiba (View Usage). After Feiba was administered, patient had the following side effects: cardiopulmonary failure, multi-organ failure. Feiba dosage: . During the same period patient was treated with HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), LASIX (View Lasix Review and Lasix Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ).

6931957-2 |
Patient was taking Feiba (View Usage). on Aug 16, 2010 from UNITED STATES Additional patient health information: Male patient , 32 years of age, . Feiba dosage: .

6931934-1 | Disseminated Intravascular Coagulation, Nonspecific Reaction
Adverse event was reported on Aug 09, 2010 by a Female patient taking Feiba (View Usage) (Dosage: ) was diagnosed with factor viii inhibition and. Location: UNITED KINGDOM , 41 years of age, Patient had the following side effects: disseminated intravascular coagulation, nonspecific reaction.

6930053-8 | Deep Vein Thrombosis, Thrombophlebitis Superficial
on Dec 07, 2009 Female patient from FRANCE , 86 years of age, weighting 132.3 lb, was diagnosed with muscle haemorrhage, acquired haemophilia, factor viii inhibition and was treated with Feiba (View Usage). After Feiba was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), thrombophlebitis superficial. Feiba dosage: . Patient was hospitalized.

6928349-9 | Disseminated Intravascular Coagulation, Multi-organ Failure, Urticaria
on Aug 06, 2010 Male patient from JAPAN , 79 years of age, weighting 101.4 lb, was diagnosed with haemostasis, acquired haemophilia and was treated with Feiba (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, multi-organ failure, urticaria. Feiba dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), ENDOXAN (View Endoxan Review and Endoxan Label ).

6900165-3 | Disseminated Intravascular Coagulation, Haemoglobin Decreased, Multi-organ Failure
Patient was taking Feiba (View Usage). Patient had the following side effects: disseminated intravascular coagulation, haemoglobin decreased, multi-organ failure on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, weighting 88.18 lb, was diagnosed with haemostasis and. Feiba dosage: .

6800992-7 | Ileus Paralytic
Adverse event was reported on Jun 21, 2010 by a Male patient taking Feiba (View Usage) (Dosage: ) was diagnosed with haemostasis, factor viii deficiency, factor viii inhibition and. Location: FINLAND , 59 years of age, weighting 216.1 lb, After Feiba was administered, patient had the following side effects: ileus paralytic. During the same period patient was treated with NOVOSEVEN (View Novoseven Review and Novoseven Label ). Patient was hospitalized.

6764103-9 | Anaphylactic Reaction
on Jun 02, 2010 Male patient from GERMANY , child 8 years of age, was diagnosed with factor viii inhibition, factor viii deficiency and was treated with Feiba (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Feiba dosage: . During the same period patient was treated with NOVOSEVEN (View Novoseven Review and Novoseven Label ).

6749137-2 | Chest Pain, Dyspnoea
on May 26, 2010 Male patient from GERMANY , child 8 years of age, was diagnosed with haemarthrosis and was treated with Feiba (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea. Feiba dosage: .

6718924-9 | Ileus Paralytic
Patient was taking Feiba (View Usage). After Feiba was administered, patient had the following side effects: ileus paralytic on May 03, 2010 from FINLAND Additional patient health information: Male patient , 59 years of age, weighting 216.1 lb, was diagnosed with haemostasis, factor viii deficiency, factor viii inhibition and. Feiba dosage: . During the same period patient was treated with NOVOSEVEN (View Novoseven Review and Novoseven Label ). Patient was hospitalized.

6142261-7 | Dyspnoea, Erythema
Adverse event was reported on Apr 02, 2009 by a Male patient taking Feiba (View Usage) (Dosage: 4908 Prn Iv Bolus) was diagnosed with haemophilia and. Location: UNITED STATES , weighting 178.0 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, erythema. Patient was hospitalized.

6129134-0 | Chest Discomfort, Dyspnoea, Flushing, Rash
on Mar 23, 2009 Male patient from UNITED STATES , child 11 years of age, was diagnosed with haemophilia and was treated with Feiba (View Usage). Patient had the following side effects: chest discomfort, dyspnoea, flushing, rash (What is rash?). Feiba dosage: 4786 Units Iv.

5871245-9 | Agitation, Atelectasis, Atrial Thrombosis, Breath Sounds Abnormal, Central Line Infection, Contusion, Cough, Decreased Activity, Echocardiogram Abnormal
on Sep 03, 2008 Male patient from UNITED STATES , weighting 35.27 lb, was diagnosed with haemophilia, prophylaxis and was treated with Feiba (View Usage). After Feiba was administered, patient had the following side effects: agitation, atelectasis, atrial thrombosis, breath sounds abnormal, central line infection, contusion, cough, decreased activity, echocardiogram abnormal. Feiba dosage: .

5486971-3 | Infusion Related Reaction, Pyrexia, Tremor, Vomiting
Patient was taking Feiba (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, pyrexia, tremor, vomiting on Oct 12, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with factor viii inhibition and. Feiba dosage: 4074 Units Every 1-2 Days Iv Bolus. Patient was hospitalized.